SCI & TECH● LOWJul 17 · Jul 17, 2026, 6:45 AM
Telix Completes Patient Enrollment in TLX591 - Px ( Illuccix ) Japan Phase 3 Study
malaysiasun.com · Malaysia
Telix has completed patient enrollment for a Phase 3 study of its product TLX591-Px (Illuccix) in Japan. This marks a significant milestone in the product's clinical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from Malaysia
BUSINESS2h agoIspire signals fiscal 2027 as first year of Malaysia production while outlining potential IKE liquidity eventSeeking Alpha TechPOLITICS5h agoMalaysia to invite Myanmar’s Min Aung Hlaing for Rohingya repatriation talksSouth China Morning PostPOLITICS13h agoMalaysian councillor resigns after DAP remarks at Umno assemblySouth China Morning PostPOLITICS13h agoMalaysia says it won’t allow shipments supporting Israel’s military through its portsPremium Times
More in Sci & Tech
SCI & TECH22m agoT. rex was warm-blooded and had body temperature close to ours, study findsSouth China Morning PostSCI & TECH39m agoAnthropic policy chief says AI companies can't be expected to operate on 'honor code'CNBCSCI & TECH1h agoZuckerberg: AI companies incentivized toward safetyThe HillSCI & TECH1h agoSacks: Trump cutting through panic over AIPolitico Tech